pe
pep-05405 v1 CC-BY-SA-4.0

LEAP2 antiviral peptide

A short protein fragment studied as a potential virus-fighting treatment; experimental, not an approved drug.

statusbioassayed targetANTIMICROBIAL length46 aa refs1
antiviral
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 0 verified on platform
prediction metrics boltz-2 2.2.1
ipTM0.000
pTM0.577
avg pLDDT72.0
ranking score0.692
STRUCTURE · PEP-05405 × ANTIMICROBIAL
ranking0.692
?
RECEPTOR UNKNOWN
peptide conformation only · no target structure
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
sequence46 aa
15101520253035404546
MTPLWRIMNSKPFGAY CQNNYECSTGLCRAGH CSTSHRATSETVNY
in the news 6 articles
details expand to inspect
full evidence table1 metrics
metricvaluetool
ranking score 0.6917067170143127 boltz-2
3-letter notation
Met-Thr-Pro-Leu-Trp-Arg-Ile-Met-Asn-Ser-Lys-Pro-Phe-Gly-Ala-Tyr-Cys-Gln-Asn-Asn-Tyr-Glu-Cys-Ser-Thr-Gly-Leu-Cys-Arg-Ala-Gly-His-Cys-Ser-Thr-Ser-His-Arg-Ala-Thr-Ser-Glu-Thr-Val-Asn-Tyr
recipeboltz-2 2.2.1
parametervalue
modelboltz-2 2.2.1
weights
hardwarevast_v100_32gb
mlx version
python
random seed1
msa strategynone_monomer
runtime
predicted by
predicted at2026-05-23
citationbibtex
peptidemodel (2026). LEAP2 antiviral peptide (pep-05405, v1). PeptideModel. https://peptidemodel.com/card/pep-05405
@peptide{pep05405,
  sequence = {MTPLWRIMNSKPFGAYCQNNYECSTGLCRAGHCSTSHRATSETVNY},
  target   = {antimicrobial},
  author   = {peptidemodel},
  year     = {2026},
  status   = {bioassayed}
}
references 1 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use